Colorectal Cancer Survivors' Receptivity toward Genomic Testing and Targeted Use of Non-Steroidal Anti-Inflammatory Drugs to Prevent Cancer Recurrence.

O'Malley, Denalee M; Blair, Cindy K; Greenbaum, Alissa; Wiggins, Charles L; Rajput, Ashwani; Chiu, Vi K; Kinney, Anita Y

O'Malley, Denalee M; Blair, Cindy K; Greenbaum, Alissa; Wiggins, Charles L; Rajput, Ashwani; Chiu, Vi K; Kinney, Anita Y.

Afiliação

O'Malley DM; The State University of New Jersey, New Brunswick, NJ, USA. omalledm@rwjms.rutgers.edu.
Blair CK; Rutgers Biomedical and Health Sciences, New Brunswick, NJ, USA. omalledm@rwjms.rutgers.edu.
Greenbaum A; Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, 112 Paterson St, New Brunswick, NJ, USA. omalledm@rwjms.rutgers.edu.
Wiggins CL; Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, USA. omalledm@rwjms.rutgers.edu.
Rajput A; Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Chiu VK; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
Kinney AY; The State University of New Jersey, New Brunswick, NJ, USA.

J Community Genet ; 13(2): 201-214, 2022 Apr.

Article em En | MEDLINE | ID: mdl-34997901

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: J Community Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google